U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C28H22NO6P
Molecular Weight 499.4511
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FOSQUIDONE

SMILES

CC1C2=C3C(=CN2CC4=CC=CC=C14)C(=O)C5=C(OP(O)(=O)OCC6=CC=CC=C6)C=CC=C5C3=O

InChI

InChIKey=UXTSQCOOUJTIAC-UHFFFAOYSA-N
InChI=1S/C28H22NO6P/c1-17-20-11-6-5-10-19(20)14-29-15-22-25(26(17)29)27(30)21-12-7-13-23(24(21)28(22)31)35-36(32,33)34-16-18-8-3-2-4-9-18/h2-13,15,17H,14,16H2,1H3,(H,32,33)

HIDE SMILES / InChI
Fosquidone (also known as GR63178A), a pentacyclic pyrroloquinone that was developed as an anticancer agent. Fosquidone participated in phase II clinical trial for the treatment of patients with colorectal, renal and non-small cell lung cancer. However, the drug didn’t show significant antitumor activity. The further development of this drug was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
1990 May
Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials Committee.
1992 Apr
Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week schedule.
1992 May
Stability of GR63178A, a novel pentacyclic pyrroloquinone anticancer compound, in aqueous solutions and biological fluids.
1993 Jan
Patents

Sample Use Guides

The drug was given intravenously as a 20 min infusion at the dose of 120 mg-2 on days 1 to 5 every 3 weeks.
Route of Administration: Intravenous
Name Type Language
FOSQUIDONE
INN   USAN  
INN   USAN  
Official Name English
FOSQUIDONE [USAN]
Common Name English
BENZYL (±)-5,8,13,14-TETRAHYDRO-14-METHYL-8,13-DIOXOBENZ(5,6)ISOINDOLO(2,1-B)ISOQUINOLIN-9-YL HYDROGEN PHOSPHATE
Systematic Name English
fosquidone [INN]
Common Name English
GR-63178K
Code English
GR 63178K
Code English
PHOSPHORIC ACID, MONO(PHENYLMETHYL) MONO(5,8,13,14-TETRAHYDRO-14-METHYL-8,13-DIOXOBENZ(5,6)ISOINDOLO(2,1-B)ISOQUINOLIN-9-YL) ESTER, (±)-
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C274
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
Code System Code Type Description
ChEMBL
CHEMBL2009105
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
CAS
114517-02-1
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
USAN
CC-83
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
MESH
C072687
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
NCI_THESAURUS
C1371
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
EVMPD
SUB07806MIG
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
PUBCHEM
71328
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
SMS_ID
100000080443
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
EPA CompTox
DTXSID00921408
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
FDA UNII
FD6QP9BP8U
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY
INN
6520
Created by admin on Sat Dec 16 17:41:58 GMT 2023 , Edited by admin on Sat Dec 16 17:41:58 GMT 2023
PRIMARY